BBMRI-ERIC Podcast

BBMRI-ERIC
  • 0.0 (0)
  • Life Sciences

A podcast that tells the latest success stories and innovations from across the European biobanking and biomolecular resources landscape.

  1. 41 - Congress Radio Insights from Europe Biobank Week 2026: What’s so important about the Biotech Act?

    1 day ago

    41 - Congress Radio Insights from Europe Biobank Week 2026: What’s so important about the Biotech Act?

    These episodes aim to give you insights from the congress that took place in Prague from 19-22 May 2026. This episode, recorded on 21 May, introduces you to Aneta Tyszkiewicz who is Director, Science and Regulatory at the European Federation of Pharmaceutical Industries and Associations (EFPIA). They represent the R&D-based pharmaceutical industry in Europe. Aneta leads EFPIA’s policy and advocacy on data, real-world evidence and emerging technologies, including biotechnologies. Her work focuses on advancing the digital transformation of healthcare in Europe to enable the development of innovative, trusted solutions that deliver tangible benefits for patients. Aneta’s keynote was titled ‘From scientific excellence to industrial leadership: Strengthening Europe’s attractiveness for research and innovation through the EU Biotech Act’. Listen to this interview to hear why the Act has the potential to unlock Europe’s biotechnology research potential, support new patient therapies and why it is relevant for the biobanking community. Links: EFPIA: https://www.efpia.euEurope Biobank Week: https://www.europebiobankweek.euBBMRI-ERIC: https://www.bbmri-eric.euESBB: https://esbb.org

    13 min
  2. 40 - Congress Radio Insights from Europe Biobank Week 2026: Returning biobank data to participants

    21 May

    40 - Congress Radio Insights from Europe Biobank Week 2026: Returning biobank data to participants

    This episode, recorded on 21st May, is handled by two speakers from the EP PerMed session. The European Partnership for Personalised Medicine panel was a discussion between stakeholders on the process of returning to people data coming from genetic/genomic studies. This is important for good research practice, people engagement, willingness to share health data and enhancing public trust in science.  These episodes aim to give you insights from the congress taking place in Prague from 19-22 May 2026. EBW is jointly organised between BBMRI-ERIC and ESBB and unites over 750 biobankers, researchers, industry specialists and decision makers from across the life sciences. Links: EP PerMed: https://www.eppermed.euHelsinki Biobank: https://www.helsinki.fi/en/infrastructures/biobank-platform/services-and-infrastructures/helsinki-biobankRadboud Biobank: https://www.radboudumc.nl/en/research/technology-centers/radboud-biobankEurope Biobank Week: https://www.europebiobankweek.euBBMRI-ERIC: https://www.bbmri-eric.euESBB: https://esbb.org

    10 min
  3. 39 - Congress Radio Insights from Europe Biobank Week 2026: Climate change and rising infectious diseases

    20 May

    39 - Congress Radio Insights from Europe Biobank Week 2026: Climate change and rising infectious diseases

    This Europe Biobank Week Congress mini-series is part of the BBMRI-ERIC Podcast. These episodes aim to give you glimpses into the congress taking place in Prague from 19-22 May 2026.   EBW is jointly organised between BBMRI-ERIC and ESBB and unites over 750 biobankers, researchers, industry specialists and decision makers from across the life sciences.  This episode, recorded on 20th May, introduces you to Professor Joacim Rocklöv - a globally recognised expert in climate change, infectious diseases, and data science. He is an Alexander von Humboldt Professor at Heidelberg University with a focus on the modelling of climate-sensitive infectious diseases. Joacim heads the Heidelberg Planetary Health Hub leading his team to conduct research to advance health surveillance, pandemic preparedness, and data-driven solutions to global health challenges. He delivered our first keynote and it was titled ‘How is climate change affecting infectious disease dynamics across Europe’. This interview picks up on some of the key issues. Links: Heidelberg Planetary Health Hub: https://hei-planet.comEurope Biobank Week: https://www.europebiobankweek.euBBMRI-ERIC: https://www.bbmri-eric.euESBB: https://esbb.org

    13 min
  4. 38 - Congress Radio Insights from Europe Biobank Week 2026: Biobanking, patients and public

    19 May

    38 - Congress Radio Insights from Europe Biobank Week 2026: Biobanking, patients and public

    This Europe Biobank Week Congress mini-series is part of the BBMRI-ERIC Podcast. These episodes aim to give you glimpses into the congress taking place in Prague from 19-22 May 2026.   EBW is jointly organised between BBMRI-ERIC and ESBB and unites over 750 biobankers, researchers, industry specialists and decision makers from across the life sciences. This year there are 104 oral and 155 poster presentations covering the latest scientific topics – see the programme at europebiobankweek.eu.   This episode, recorded on 19 May, explores including patients and the public in biobanking at all stages of collection and research. Let's meet our expert, Eric Vermeulen, who will share those insights.   Links: Stakeholder Forum Patient and Public Pillar: https://www.bbmri-eric.eu/stakeholder-forum/Europe Biobank Week: https://www.europebiobankweek.euBBMRI-ERIC: https://www.bbmri-eric.euESBB: https://esbb.org

    6 min
  5. 37 - ELSI Dialogues: The role of biobanks in realising the One Health approach

    21 Apr

    37 - ELSI Dialogues: The role of biobanks in realising the One Health approach

    “One Health is fundamentally about cooperation.” (Prof. Jabob Zinsstag) On 24 March 2026, three expert speakers joined us for a new ELSI Dialogues webinar to discuss the role biobanks can play in realising the One Health strategy. Josephine Uldry, Jakob Zinsstag and Adam Strobeyko discussed One Health from philosophical, societal, legal and practical perspectives, highlighting the complexity of the topic. This webinar opens with a short introduction by Josephine Uldry (Swiss Biobanking), outlining the means for the biobanking community to support a One Health approach in research. Prof. Jakob Zinsstag (Swiss Tropical and Public Health Institute), a pioneer of the One Health concept, shares insights from his extensive field experience in implementing this approach in diverse contexts and communities, illustrating how One Health approaches can improve epidemiology and public health policy in practice. Dr Adam Strobeyko (Swiss Biobanking and Global Health Centre, Geneva Graduate Institute) discusses the legal dimensions of pandemic prevention, preparedness, and response the efforts to integrate One Health into international frameworks and practical implications for biobanks. About One HealthThe goal of One Health is to balance and optimise the health of humans, animals, plants and the environment. This view moves away from an anthropocentric approach centred around humans and recognises how tightly these realms and their health are interwoven. This is a crucial step towards a healthier future as it is especially important for tackling emerging zoonotic diseases (infectious diseases transmitted from non-human animals to humans), antimicrobial resistance, food safety risks, environmental pollution and global health security. Biobanks at the centre of One HealthBiobanking across human and non-human domains can play a key role in operationalising the One Health approach. They can support the collection, storage and sharing of human, animal, plant and environmental samples and data as indispensable resources for surveillance, research and policymaking.   BBMRI-ERIC and One Health Our recently published 10-Year Roadmap (2025-2035) and our current Work Programme (2025-2027) are guided by the One Health approach as clear direction for our strategic development and actions. Follow our news on the website and on our socials for more info and future updates on the topic.   🔗 Watch the video recording here.

    57 min
  6. 36 - Strengthening Biobanks through Patient & Public involvement – A BBMRI-ERIC Stakeholder Forum webinar

    23 Feb

    36 - Strengthening Biobanks through Patient & Public involvement – A BBMRI-ERIC Stakeholder Forum webinar

    Engagement and involvement are not possible if you don't have trust. (Sara Rebbling) Constant dialogue with patients, caregivers and the public is a key guiding principle in biobanking and research. Yet, public and patient involvement, often referred to also as research participant involvement, has not yet become the usual practice in many biobanks. This episode lets you revisit the first webinar organised by the BBMRI-ERIC Stakeholder Forum recorded on 4 February 2026. Focus is on the importance and benefits of involving patients and public representatives as co-partners in biobanking and research - the core mission of the Stakeholder Forum. They speak with the voices of lived experience and knowledge and can take a crucial role in shaping the biobanking ecosystem. Four invited speakers - biobankers and patient representatives - discussed best practices on engagement and involvement and also addressed currently existing barriers and challenges. Sara Rebbling (Biobank Sweden) and Ronny Baber shared their experiences from the biobanking side whereas Eric Vermeulen (Chair of the BBMRI-ERIC Stakeholder Forum Patients’ and Citizens’ Pillar) and Albert Counet (President of Ligue Huntington Francophone Belge) addressed the topic from the patient persepective. Together, they explored practical solutions to strengthen participation and co-creation in biobanking. Enjoy the recording of the webinar also here on Youtube and stay tuned for future webinars by the BBMRI-ERIC Stakeholder Forum. You can always find upcoming events and webinar here on our homepage. Speakers: Eric Vermeulen, Chair of BBMRI-ERIC Stakeholder Forum Patients’ and Citizens’ Pillar and Patient Participation Advisor at PostCovid NLRonny Baber, Head of the Leipzig Medical BiobankSara Rebbling, Member of Biobank Sweden’s citizen engagement team and Department manager at Biobanken norr, Region VästerbottenAlbert Counet, President of Ligue Huntington Francophone Belge and member of the BBMRI-ERIC Stakeholder Forum Patients’ and Citizens’ PillarHost: Manuela Pausan, BBMRI-ERIC

    54 min
  7. 35 - ELSI Dialogues: Trustworthy by Design: Ethics, Practice and Impact of AI in Cancer Research and Care

    17/12/2025

    35 - ELSI Dialogues: Trustworthy by Design: Ethics, Practice and Impact of AI in Cancer Research and Care

    The potential of artificial intelligence (AI) to improve cancer diagnostics, treatment plans and patient outcomes is immense, particularly when it comes to medical imaging. But what does it mean for AI to be truly trustworthy in practice? What do experts and patients need to develop trust in such potentially revolutionary new tools and how can we incorporate human needs early-on to ensure AI is trustworthy by design? In the latest ELSI Dialogues session in October 2025, two invited experts, Macej Bobowicz, MD, PhD (Medical University of Gdansk) and Prof. Karim Lekadir (University of Barcelona), shared their thoughts and expertise on this highly current topic. The session was recorded on 28 October 2025 and moderated by Dr. Melanie Goisauf (BBMRI-ERIC). Read our website article about the webinar for more details and insights. About the speakers:Dr. Maciej Bobowicz (Medical University of Gdańsk) Dr Maciej Bobowicz is an Assistant Professor at the 2nd Department of Radiology, Medical University of Gdańsk, Poland, and a surgical oncologist specialising in breast cancer diagnostics and treatment. His research focuses on the ethical and clinically responsible use of artificial intelligence in oncology, radiomics, and precision medicine. He leads or contributes to several EU-funded projects, including EuCanImage, RadioVal, MAYA, Cinderella, TRACE and CAREWAY. He is also part of the AI4HI network, which supports the EUCAIM initiative under Europe’s Beating Cancer Plan. Author of over 80 scientific papers, Dr Bobowicz is committed to advancing patient-centred, trustworthy, and equitable AI applications in cancer imaging and care. Prof. Karim Lekadir (University of Barcelona) Karim Lekadir is an ICREA Research Professor in the Department of Mathematics and Computer Science at the University of Barcelona. He obtained his PhD from Imperial College London and was a postdoctoral researcher at Stanford University. He investigates new data science techniques for trustworthy and ethical artificial intelligence in medicine. He has been PI in 15 EU-funded projects, coordinated 6 Horizon projects, and was awarded an ERC Consolidator grant to investigate new AI techniques tailored to resource-limited settings. Moderator: Melanie Goisauf (BBMRI-ERIC) Dr. Melanie Goisauf is an accomplished social scientist with a PhD in Sociology (University of Vienna). She also studied at the Royal Holloway University of London and completed the postgraduate programme “Sociology of Social Practices” at the Institute for Advanced Studies (IHS) Vienna. As senior scientist at BBMRI-ERIC she is involved in several research projects and serves on ethical advisory boards. Dr. Goisauf also leads the Ethics of AI Lab, which focuses on the ethical and social implications of artificial intelligence, and is in charge of the scientific coordination of the Horizon Europe project PERIFORMANCE.

    51 min
  8. 34 - Ángel Álvarez-Prado profile: “I think it was game changing in my career. It was just a once in a lifetime experience.”

    18/09/2025

    34 - Ángel Álvarez-Prado profile: “I think it was game changing in my career. It was just a once in a lifetime experience.”

    Meet Dr. Ángel Álvarez-Prado, principal investigator at the Translational Cancer Immunogenomics Lab at the Luxembourg Institute of Health. His journey took him from a curious child and self-described “computer nerd” to the head of his own laboratory, dedicated to advancing cancer treatment. Ángel first crossed paths with BBMRI-ERIC in 2023 while working as a postdoctoral fellow at the Ludwig Institute for Cancer Research at the University of Lausanne. He was selected to participate in the Lindau Nobel Laureate Meeting, an annual event where young scientists have the rare opportunity to engage with Nobel Laureates and explore breakthroughs in their fields. BBMRI-ERIC sponsored Ángel’s participation and the experience helped spark his motivation to become independent and establish his own translational research lab. Later, as his dream of building a lab began to take shape, Ángel started analysing clinical samples and BBMRI-ERIC played a key role by helping him identify suitable collections for his research and by streamlining access to them. In today’s episode, Angel shares his research, his vision for personalised cancer therapies and offers advice to aspiring scientists considering a career in research.  Further reading:  Lindau Nobel Laureate Meeting: https://www.lindau-nobel.org/ BBMRI Podcast: https://www.bbmri-eric.eu/bbmri-eric/bbmri-eric-podcast/

    21 min
See All (41)

About

A podcast that tells the latest success stories and innovations from across the European biobanking and biomolecular resources landscape.

Information

  • Creator
    BBMRI-ERIC
  • Years Active
    2022 - 2026
  • Episodes
    41
  • Rating
    Clean
  • Copyright
    © All rights reserved.
  • Show Website
    BBMRI-ERIC Podcast